| |
|
|
|
Genmark Diagnostics  
|
|
11.09 -0.32 (-0.03%) |
10-21 16:00 |
|
Open: |
11.36 |
Pre close: |
11.41 |
Target:
|
16.24 
|
|
High: |
11.47 |
Low: |
10.92 |
Resistance:
|
13.90
15.75
|
|
Volume: |
672,286 |
Market Cap: |
788M |
Support:
|
10.92
9.09
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
11.57
|
MACD |
MACD(12,26):
|
-0.61 |
|
MA(20): |
13.11 |
Signal(12,26,9): |
-0.34 |
|
MA(100): |
14.17  |
Stochastic Oscillator |
%K(14,3):
|
3.16 |
|
MA(250): |
9.42 |
%D(3): |
4.90 |
|
Average Volume(K) |
3-Month: |
118111
|
52-Week |
High:
|
20.88 |
|
10-Days: |
145228 |
Low: |
3.36 |
|
RSI |
RSI(14):
|
34.66 |
Change(%): |
91.2 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.550 |
Return on Equity (ttm) |
-64.1 |
Shares Out. (M) |
71.07 |
|
EPS Est. Current Year |
-1.070 |
Return on Assets (ttm) |
-10.3 |
Shares Float (M) |
55.49 |
|
EPS Est. Next Year |
-0.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
4.70 |
|
EPS Est. Next Quarter |
-0.140 |
Qtrly Rev. Growth |
118.2 |
% Held by Institutions |
91.80 |
|
Forward EPS |
-0.820 |
Gross Profit (p.s.) |
0.402 |
Shares Short (K) |
7310 |
|
Book Value (p.s.) |
1.280 |
EBITDA (p.s.) |
-0.236 |
P/E |
-20.16 |
|
Sales Per Share |
1.786 |
Qtrly Earnings Growth |
0.00 |
P/BV |
8.66 |
|
Profit Margin |
-26.51 |
Operating Cash Flow
(M) |
-18.93 |
P/S |
6.21 |
|
Operating Margin |
-18.28 |
Levered Free Cash Flow
(M) |
-3.29 |
P/CF |
-41.64 |
|
|
|
|
|
|
